Abbott Laboratories (ABT)
USD 111.93
(-1.2%)
USD 111.93
(-1.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 22.13 Billion USD | -9.7% |
| 2022 | 24.51 Billion USD | -0.11% |
| 2021 | 24.53 Billion USD | 25.16% |
| 2020 | 19.6 Billion USD | 4.99% |
| 2019 | 18.67 Billion USD | 4.48% |
| 2018 | 17.87 Billion USD | 18.73% |
| 2017 | 15.05 Billion USD | 27.26% |
| 2016 | 11.82 Billion USD | 1.47% |
| 2015 | 11.65 Billion USD | 5.7% |
| 2014 | 11.02 Billion USD | -6.6% |
| 2013 | 11.8 Billion USD | -52.3% |
| 2012 | 24.75 Billion USD | 6.19% |
| 2011 | 23.31 Billion USD | 13.7% |
| 2010 | 20.5 Billion USD | 16.78% |
| 2009 | 17.55 Billion USD | 3.79% |
| 2008 | 16.91 Billion USD | 16.72% |
| 2007 | 14.49 Billion USD | 14.46% |
| 2006 | 12.66 Billion USD | 8.25% |
| 2005 | 11.69 Billion USD | 8.34% |
| 2004 | 10.79 Billion USD | 5.77% |
| 2003 | 10.2 Billion USD | 11.21% |
| 2002 | 9.17 Billion USD | 7.51% |
| 2001 | 8.53 Billion USD | 13.71% |
| 2000 | 7.5 Billion USD | 4.26% |
| 1999 | 7.2 Billion USD | 1.65% |
| 1998 | 7.08 Billion USD | 3.59% |
| 1997 | 6.83 Billion USD | 8.86% |
| 1996 | 6.28 Billion USD | 10.46% |
| 1995 | 5.68 Billion USD | 10.15% |
| 1994 | 5.16 Billion USD | 9.3% |
| 1993 | 4.72 Billion USD | -1.07% |
| 1992 | 4.77 Billion USD | 16.01% |
| 1991 | 4.11 Billion USD | 14.18% |
| 1990 | 3.6 Billion USD | 15.14% |
| 1989 | 3.13 Billion USD | 9.66% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 5.8 Billion USD | 4.74% |
| 2024 Q1 | 5.54 Billion USD | 5.44% |
| 2024 Q3 | 5.93 Billion USD | 2.24% |
| 2023 Q2 | 5.49 Billion USD | 1.14% |
| 2023 Q4 | 5.25 Billion USD | -5.06% |
| 2023 Q3 | 5.53 Billion USD | 0.78% |
| 2023 FY | 22.13 Billion USD | -9.7% |
| 2023 Q1 | 5.43 Billion USD | -1.18% |
| 2022 FY | 24.51 Billion USD | -0.11% |
| 2022 Q1 | 6.9 Billion USD | 3.07% |
| 2022 Q2 | 6.32 Billion USD | -8.45% |
| 2022 Q3 | 5.78 Billion USD | -8.59% |
| 2022 Q4 | 5.49 Billion USD | -4.9% |
| 2021 Q4 | 6.7 Billion USD | 3.03% |
| 2021 FY | 24.53 Billion USD | 25.16% |
| 2021 Q2 | 5.27 Billion USD | -12.87% |
| 2021 Q1 | 6.05 Billion USD | -2.46% |
| 2021 Q3 | 6.5 Billion USD | 23.29% |
| 2020 Q3 | 4.88 Billion USD | 20.22% |
| 2020 Q1 | 4.44 Billion USD | -8.91% |
| 2020 FY | 19.6 Billion USD | 4.99% |
| 2020 Q4 | 6.2 Billion USD | 27.03% |
| 2020 Q2 | 4.06 Billion USD | -8.55% |
| 2019 Q2 | 4.7 Billion USD | 7.43% |
| 2019 Q4 | 4.88 Billion USD | 3.43% |
| 2019 FY | 18.67 Billion USD | 4.48% |
| 2019 Q1 | 4.37 Billion USD | -4.35% |
| 2019 Q3 | 4.71 Billion USD | 0.38% |
| 2018 FY | 17.87 Billion USD | 18.73% |
| 2018 Q1 | 4.32 Billion USD | -0.07% |
| 2018 Q2 | 4.48 Billion USD | 3.75% |
| 2018 Q4 | 4.57 Billion USD | 1.87% |
| 2018 Q3 | 4.49 Billion USD | 0.11% |
| 2017 Q3 | 3.97 Billion USD | 14.67% |
| 2017 Q1 | 3.29 Billion USD | 8.94% |
| 2017 Q2 | 3.46 Billion USD | 5.26% |
| 2017 Q4 | 4.32 Billion USD | 8.91% |
| 2017 FY | 15.05 Billion USD | 27.26% |
| 2016 Q1 | 2.74 Billion USD | -7.95% |
| 2016 FY | 11.82 Billion USD | 1.47% |
| 2016 Q3 | 3.01 Billion USD | -0.95% |
| 2016 Q4 | 3.02 Billion USD | 0.13% |
| 2016 Q2 | 3.04 Billion USD | 10.97% |
| 2015 FY | 11.65 Billion USD | 5.7% |
| 2015 Q4 | 2.98 Billion USD | 2.54% |
| 2015 Q2 | 2.95 Billion USD | 4.83% |
| 2015 Q3 | 2.9 Billion USD | -1.49% |
| 2015 Q1 | 2.81 Billion USD | -6.72% |
| 2014 Q2 | 3.04 Billion USD | 9.77% |
| 2014 FY | 11.02 Billion USD | -6.6% |
| 2014 Q3 | 2.77 Billion USD | -8.93% |
| 2014 Q1 | 2.77 Billion USD | -8.81% |
| 2014 Q4 | 3.01 Billion USD | 8.87% |
| 2013 Q1 | 2.94 Billion USD | -56.53% |
| 2013 FY | 11.8 Billion USD | -52.3% |
| 2013 Q4 | 3.04 Billion USD | 4.21% |
| 2013 Q3 | 2.91 Billion USD | 0.62% |
| 2013 Q2 | 2.9 Billion USD | -1.53% |
| 2012 Q4 | 6.77 Billion USD | 11.56% |
| 2012 FY | 24.75 Billion USD | 6.19% |
| 2012 Q1 | 5.73 Billion USD | -12.35% |
| 2012 Q2 | 6.17 Billion USD | 7.64% |
| 2012 Q3 | 6.07 Billion USD | -1.54% |
| 2011 Q2 | 5.74 Billion USD | 10.88% |
| 2011 Q3 | 5.84 Billion USD | 1.71% |
| 2011 Q4 | 6.53 Billion USD | 11.9% |
| 2011 FY | 23.31 Billion USD | 13.7% |
| 2011 Q1 | 5.18 Billion USD | -12.51% |
| 2010 Q3 | 4.93 Billion USD | -6.61% |
| 2010 FY | 20.5 Billion USD | 16.78% |
| 2010 Q1 | 4.36 Billion USD | -12.84% |
| 2010 Q2 | 5.28 Billion USD | 21.06% |
| 2010 Q4 | 5.92 Billion USD | 20.07% |
| 2009 FY | 17.55 Billion USD | 3.79% |
| 2009 Q3 | 4.4 Billion USD | 0.8% |
| 2009 Q4 | 5 Billion USD | 13.74% |
| 2009 Q1 | 3.78 Billion USD | -20.73% |
| 2009 Q2 | 4.36 Billion USD | 15.43% |
| 2008 Q3 | 4.14 Billion USD | -1.18% |
| 2008 FY | 16.91 Billion USD | 16.72% |
| 2008 Q4 | 4.77 Billion USD | 15.13% |
| 2008 Q2 | 4.19 Billion USD | 10.25% |
| 2008 Q1 | 3.8 Billion USD | -6.28% |
| 2007 Q2 | 3.56 Billion USD | 14.54% |
| 2007 Q1 | 3.11 Billion USD | -7.12% |
| 2007 Q4 | 4.05 Billion USD | 15.57% |
| 2007 FY | 14.49 Billion USD | 14.46% |
| 2007 Q3 | 3.51 Billion USD | -1.5% |
| 2006 Q4 | 3.35 Billion USD | 5.34% |
| 2006 Q3 | 3.18 Billion USD | 2.25% |
| 2006 FY | 12.66 Billion USD | 8.25% |
| 2006 Q2 | 3.11 Billion USD | 3.28% |
| 2006 Q1 | 3.01 Billion USD | -6.92% |
| 2005 Q3 | 2.7 Billion USD | -6.4% |
| 2005 Q1 | 2.86 Billion USD | -5.52% |
| 2005 FY | 11.69 Billion USD | 8.34% |
| 2005 Q4 | 3.23 Billion USD | 19.62% |
| 2005 Q2 | 2.89 Billion USD | 1.11% |
| 2004 Q3 | 2.56 Billion USD | -2.57% |
| 2004 Q1 | 2.73 Billion USD | -4.76% |
| 2004 Q2 | 2.63 Billion USD | -3.71% |
| 2004 Q4 | 3.02 Billion USD | 17.94% |
| 2004 FY | 10.79 Billion USD | 5.77% |
| 2003 Q1 | 2.38 Billion USD | -3.27% |
| 2003 Q2 | 2.45 Billion USD | 2.94% |
| 2003 Q3 | 2.49 Billion USD | 1.89% |
| 2003 Q4 | 2.87 Billion USD | 14.95% |
| 2003 FY | 10.2 Billion USD | 11.21% |
| 2002 Q1 | 2.29 Billion USD | -2.99% |
| 2002 Q4 | 2.46 Billion USD | 8.33% |
| 2002 FY | 9.17 Billion USD | 7.51% |
| 2002 Q3 | 2.27 Billion USD | 5.84% |
| 2002 Q2 | 2.14 Billion USD | -6.32% |
| 2001 Q2 | 2.11 Billion USD | 10.41% |
| 2001 Q3 | 2.14 Billion USD | 1.15% |
| 2001 Q4 | 2.36 Billion USD | 10.45% |
| 2001 FY | 8.53 Billion USD | 13.71% |
| 2001 Q1 | 1.91 Billion USD | -4.57% |
| 2000 Q1 | 1.85 Billion USD | -6.32% |
| 2000 Q2 | 1.83 Billion USD | -0.91% |
| 2000 Q3 | 1.8 Billion USD | -2.04% |
| 2000 Q4 | 2 Billion USD | 11.42% |
| 2000 FY | 7.5 Billion USD | 4.26% |
| 1999 Q2 | 1.83 Billion USD | -0.97% |
| 1999 Q4 | 1.98 Billion USD | 29.03% |
| 1999 Q1 | 1.85 Billion USD | -2.04% |
| 1999 FY | 7.2 Billion USD | 1.65% |
| 1999 Q3 | 1.53 Billion USD | -16.17% |
| 1998 Q4 | 1.88 Billion USD | 13.73% |
| 1998 FY | 7.08 Billion USD | 3.59% |
| 1998 Q3 | 1.66 Billion USD | -6.12% |
| 1998 Q2 | 1.76 Billion USD | 0.23% |
| 1998 Q1 | 1.76 Billion USD | -5.04% |
| 1997 Q3 | 1.62 Billion USD | -3.57% |
| 1997 Q4 | 1.85 Billion USD | 14.49% |
| 1997 FY | 6.83 Billion USD | 8.86% |
| 1997 Q1 | 1.67 Billion USD | -3.95% |
| 1997 Q2 | 1.68 Billion USD | 0.65% |
| 1996 Q3 | 1.46 Billion USD | -5.55% |
| 1996 FY | 6.28 Billion USD | 10.46% |
| 1996 Q1 | 1.51 Billion USD | -0.01% |
| 1996 Q2 | 1.55 Billion USD | 2.59% |
| 1996 Q4 | 1.74 Billion USD | 18.54% |
| 1995 FY | 5.68 Billion USD | 10.15% |
| 1995 Q4 | 1.51 Billion USD | 14.81% |
| 1995 Q2 | 1.41 Billion USD | -1.48% |
| 1995 Q1 | 1.43 Billion USD | 1.45% |
| 1995 Q3 | 1.32 Billion USD | -6.63% |
| 1994 Q2 | 1.25 Billion USD | 0.5% |
| 1994 Q3 | 1.23 Billion USD | -1.45% |
| 1994 Q4 | 1.41 Billion USD | 14.21% |
| 1994 FY | 5.16 Billion USD | 9.3% |
| 1994 Q1 | 1.25 Billion USD | 38.33% |
| 1993 Q4 | 904.31 Million USD | -28.68% |
| 1993 FY | 4.72 Billion USD | -1.07% |
| 1993 Q2 | 1.31 Billion USD | 7.1% |
| 1993 Q1 | 1.23 Billion USD | -4.37% |
| 1993 Q3 | 1.26 Billion USD | -3.87% |
| 1992 Q3 | 1.18 Billion USD | 3.02% |
| 1992 Q2 | 1.15 Billion USD | 0.58% |
| 1992 Q4 | 1.28 Billion USD | 8.45% |
| 1992 Q1 | 1.14 Billion USD | 0.16% |
| 1992 FY | 4.77 Billion USD | 16.01% |
| 1991 Q4 | 1.14 Billion USD | 16.66% |
| 1991 FY | 4.11 Billion USD | 14.18% |
| 1991 Q2 | 1 Billion USD | 1.72% |
| 1991 Q3 | 980.9 Million USD | -2.27% |
| 1991 Q1 | 986.7 Million USD | -1.02% |
| 1990 Q4 | 996.9 Million USD | 14.63% |
| 1990 FY | 3.6 Billion USD | 15.14% |
| 1990 Q3 | 869.7 Million USD | -2.92% |
| 1990 Q2 | 895.9 Million USD | 6.39% |
| 1990 Q1 | 842.1 Million USD | -42.14% |
| 1989 Q3 | 1.31 Billion USD | -0.62% |
| 1989 Q1 | 1.29 Billion USD | -0.83% |
| 1989 Q4 | 1.45 Billion USD | 11.08% |
| 1989 Q2 | 1.31 Billion USD | 1.78% |
| 1989 FY | 3.13 Billion USD | 9.66% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Allurion Technologies Inc. | 41.49 Million USD | -53238.796% |
| Artivion, Inc. | 229.17 Million USD | -9558.079% |
| Avanos Medical, Inc. | 379.7 Million USD | -5729.339% |
| Butterfly Network, Inc. | 16.85 Million USD | -131212.292% |
| Butterfly Network, Inc. | 16.85 Million USD | -131212.292% |
| Bio-Rad Laboratories, Inc. | 1.43 Billion USD | -1446.377% |
| Boston Scientific Corporation | 9.89 Billion USD | -123.689% |
| Perspective Therapeutics, Inc. | 1.63 Million USD | -1354489.963% |
| CONMED Corporation | 643.06 Million USD | -3341.943% |
| Edwards Lifesciences Corporation | 4.62 Billion USD | -378.573% |
| Paragon 28, Inc. | 172.79 Million USD | -12709.695% |
| Glaukos Corporation | 239.13 Million USD | -9155.821% |
| Globus Medical, Inc. | 1.02 Billion USD | -2069.358% |
| Inspire Medical Systems, Inc. | 528.22 Million USD | -4090.276% |
| Integer Holdings Corporation | 418.28 Million USD | -5191.557% |
| Medtronic plc | 19.45 Billion USD | -13.782% |
| Nevro Corp. | 290.06 Million USD | -7530.835% |
| Owlet, Inc. | 22.58 Million USD | -97894.422% |
| Penumbra, Inc. | 682.64 Million USD | -3142.398% |
| Vicarious Surgical Inc. | -1.85 Million USD | 1193951.133% |
| Smith & Nephew plc | 3.7 Billion USD | -498.055% |
| Sonendo, Inc. | 10.72 Million USD | -206335.367% |
| STERIS plc | 2.23 Billion USD | -890.781% |
| Stryker Corporation | 13.05 Billion USD | -69.505% |
| Vapotherm, Inc. | 28.28 Million USD | -78159.025% |
| Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | -316.805% |